Markus Peter Schneider
Hat mitgewirkt an:
-
Validation of a novel predictive algorithm for kidney failure in patients suffering from chronic kidney disease: the prognostic reasoning system for chronic kidney disease (PROGRES-CKD)
-
The Cardiovascular Literature-Based Risk Algorithm (CALIBRA): Predicting Cardiovascular Events in Patients With Non-Dialysis Dependent Chronic Kidney Disease
-
Copeptin, natriuretic peptides, and cardiovascular outcomes in patients with CKD: the German Chronic Kidney Disease (GCKD) study
-
Novel biomarkers in patients with chronic kidney disease - an analysis of patients enrolled in the GCKD-study